Aquestive Therapeutics Inc.(AQST)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AQST Aquestive Therapeutics Inc.

休市中 05-15 16:00:00 EDT

4.17

-0.56

-11.84%

盘后4.28

+0.11+2.64%

19:59 EDT

最高4.67	最低4.16	成交量341.98万
今开4.64	昨收4.73	日振幅10.68%
总市值5.23亿	流通市值4.75亿	总股本1.25亿
成交额1,478万	换手率3.00%	流通股本1.14亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AQST","market":"US","secType":"STK","nameCN":"Aquestive Therapeutics Inc.","latestPrice":4.17,"timestamp":1778875200000,"preClose":4.73,"halted":0,"volume":3419764,"hourTrading":{"tag":"盘后","latestPrice":4.28,"preClose":4.17,"latestTime":"19:59 EDT","volume":9641,"amount":40876.1317,"timestamp":1778889577525,"change":0.11,"changeRate":0.026379,"amplitude":0.026379},"delay":0,"changeRate":-0.11839323467230453,"floatShares":113999999,"shares":125450119,"eps":-0.603,"marketStatus":"休市中","change":-0.56,"latestTime":"05-15 16:00:00 EDT","open":4.64,"high":4.665,"low":4.16,"amount":14775670.695950799,"amplitude":0.106765,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.603,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1779091200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1532491200000,"exchange":"NASDAQ","adjPreClose":4.73,"preHourTrading":{"tag":"盘前","latestPrice":4.7,"preClose":4.73,"latestTime":"09:27 EDT","volume":6305,"amount":29359.562251500003,"timestamp":1778851670049,"change":-0.03,"changeRate":-0.006342,"amplitude":0.057019},"postHourTrading":{"tag":"盘后","latestPrice":4.28,"preClose":4.17,"latestTime":"19:59 EDT","volume":9641,"amount":40876.1317,"timestamp":1778889577525,"change":0.11,"changeRate":0.026379,"amplitude":0.026379},"volumeRatio":1.3143432726829862,"impliedVol":1.0197,"impliedVolPercentile":0.506},"requestUrl":"/m/hq/s/AQST","defaultTab":"news","newsList":[{"id":"1146132419","title":"Aquestive Therapeutics公司于2026年5月12日签订高达1.5亿美元的五年期定期贷款安排 - SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1146132419","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146132419?lang=zh_cn&edition=full","pubTime":"2026-05-14 04:24","pubTimestamp":1778703854,"startTime":"0","endTime":"0","summary":"Aquestive Therapeutics Inc. 已通过一项新的融资安排为其未来运营注入资金。根据提交给美国证券交易委员会的文件，该公司于2026年5月12日签订了一份高达1.5亿美元的五年期定期贷款协议。\n此项贷款安排为公司提供了显著的财务灵活性，最高可达1.5亿美元的信贷额度将在未来五年内支持其战略计划的推进。定期贷款是一种常见的公司融资工具，通常用于资助长期资本支出、研发活动或一般企业用途。\n该协议的签订标志着Aquestive Therapeutics在加强其资产负债表和确保长期财务资源方面迈出了关键一步。详细的条款和条件可在公司提交给SEC的相关文件中查阅。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AQST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166850912","title":"Aquestive Therapeutics Inc. 持续推进Anaphylm在加拿大及欧盟的监管申报进程","url":"https://stock-news.laohu8.com/highlight/detail?id=1166850912","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166850912?lang=zh_cn&edition=full","pubTime":"2026-03-30 19:05","pubTimestamp":1774868712,"startTime":"0","endTime":"0","summary":"Aquestive Therapeutics Inc. 近日宣布，其针对Anaphylm（肾上腺素舌下膜）的监管申报工作，在加拿大与欧洲联盟两大关键市场正稳步推进。公司致力于通过监管审批途径，将这一创新疗法引入更广阔的国际市场。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AQST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174982284","title":"Aquestive Therapeutics Inc 获美国FDA就药代动力学及人因工程学研究方案提供澄清反馈","url":"https://stock-news.laohu8.com/highlight/detail?id=1174982284","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174982284?lang=zh_cn&edition=full","pubTime":"2026-03-30 19:04","pubTimestamp":1774868687,"startTime":"0","endTime":"0","summary":"Aquestive Therapeutics Inc 近日宣布，已获得美国食品药品监督管理局（FDA）针对其药代动力学（PK）研究及人因工程学（HF）研究方案所提出的澄清反馈意见。这一进展标志着公司在相关药物研发项目上取得了重要的监管沟通成果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AQST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189989229","title":"Aquestive Therapeutics完成与FDA关于Anaphylm™舌下膜的A类会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1189989229","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189989229?lang=zh_cn&edition=full","pubTime":"2026-03-30 19:01","pubTimestamp":1774868479,"startTime":"0","endTime":"0","summary":"Aquestive Therapeutics公司宣布，已成功完成与美国食品药品监督管理局（FDA）就Anaphylm™（地布肾上腺素）舌下膜制剂举行的A类会议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AQST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115734899","title":"Aquestive Therapeutics 依据纳斯达克上市规则 5635(C)(4) 授予激励性奖励","url":"https://stock-news.laohu8.com/highlight/detail?id=1115734899","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115734899?lang=zh_cn&edition=full","pubTime":"2026-03-10 04:02","pubTimestamp":1773086532,"startTime":"0","endTime":"0","summary":"Aquestive Therapeutics Inc. 宣布，公司已根据纳斯达克上市规则第5635(C)(4)条的规定，授予了一项激励性奖励。该奖励旨在吸引高素质人才加入公司，符合相关法规对新兴成长型公司的要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AQST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162366127","title":"Aquestive Therapeutics任命国际知名过敏症专家Matthew Greenhawt博士为首席医疗官","url":"https://stock-news.laohu8.com/highlight/detail?id=1162366127","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162366127?lang=zh_cn&edition=full","pubTime":"2026-02-18 20:03","pubTimestamp":1771416218,"startTime":"0","endTime":"0","summary":"Aquestive Therapeutics宣布任命国际知名过敏症专家Matthew Greenhawt博士担任公司首席医疗官。这一重要人事变动将进一步加强公司在过敏治疗领域的专业领导力。Greenhawt博士在过敏与免疫学领域拥有丰富临床经验和卓越学术成就，他的加入有望推动Aquestive Therapeutics在创新疗法研发方面的战略布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AQST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608862978","title":"Aquestive Therapeutics(AQST)盘前股价升4成 称Anaphylm新药仅包装管理需整改","url":"https://stock-news.laohu8.com/highlight/detail?id=2608862978","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608862978?lang=zh_cn&edition=full","pubTime":"2026-02-02 21:50","pubTimestamp":1770040259,"startTime":"0","endTime":"0","summary":"金吾财讯 | Aquestive Therapeutics(AQST)盘前股价拉升，暂报4.21美元，升幅42%。消息面上，公司于2026年1月30日收到了美国食品和药物管理局（FDA）发出的完整回应信（CRL），该信函针对其寻求批准用于治疗I型过敏反应（包括过敏性休克）的一款新药申请（NDA），该药品为Anaphylm（dibutepinephrine）舌下膜剂，适用于体重大于30公斤（约66磅）的患者。公司表示，该药品缺陷仅限于包装和管理。公司相信能够迅速解决缺陷，并预计最早在2026年第三季度重新提交。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/NDZhYjYzMzkxMDg4OTM4.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NDZhYjYzMzkxMDg4OTM4.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"296795","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LENZ","AQST","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158438478","title":"Aquestive Therapeutics股价暴跌37.2%，FDA通报其过敏反应实验性药物上市申请存在缺陷","url":"https://stock-news.laohu8.com/highlight/detail?id=1158438478","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158438478?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:34","pubTimestamp":1767969285,"startTime":"0","endTime":"0","summary":"因美国食品药品监督管理局（FDA）指出其针对过敏反应的实验性药物上市申请材料存在不足，Aquestive Therapeutics Inc. 股价遭遇重挫，单日跌幅高达37.2%。这一监管层面的负面消息引发了市场对该公司新药获批前景的严重担忧，导致投资者信心受挫，大规模抛售股票。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AQST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168450786","title":"Aquestive Therapeutics公布Anaphylm™舌下薄膜监管进展及业务近况","url":"https://stock-news.laohu8.com/highlight/detail?id=1168450786","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168450786?lang=zh_cn&edition=full","pubTime":"2026-01-09 20:03","pubTimestamp":1767960211,"startTime":"0","endTime":"0","summary":"Aquestive Therapeutics Inc. (AQST) 近日宣布，其研发的Anaphylm™（Dibutepinephrine）舌下薄膜在监管审批方面取得新进展，并同步更新了公司业务动态。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AQST","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518207716","title":"Aquestive Therapeutics, Inc.盘中异动 大幅下挫5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518207716","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518207716?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:53","pubTimestamp":1741632820,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时53分，Aquestive Therapeutics, Inc.股票出现波动，股价快速下挫5.09%。Aquestive Therapeutics, Inc.股票所在的制药行业中，整体跌幅为2.33%。其相关个股中，Sonoma Pharmaceuticals, Inc.、Sunshine Biopharma Inc C/Wts 、Medicus Pharma Ltd.涨幅较大，Sonoma Pharmaceuticals, Inc.、Petros Pharmaceuticals, Inc.、苏轩堂较为活跃，换手率分别为2009.40%、36.21%、28.04%，振幅较大的相关个股有Sonoma Pharmaceuticals, Inc.、Alvotech C/Wts 、Scilex Holding Company C/Wts 10/11/2027 ，振幅分别为60.30%、41.21%、35.91%。Aquestive Therapeutics, Inc.公司简介：Aquestive Therapeutics Inc 是一家专业制药公司，致力于开发和商业化差异化产品以满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102534098a2dacb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102534098a2dacb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AQST","BK4007","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518816542","title":"Aquestive Therapeutics, Inc.2024财年实现净利润-44.14百万美元，同比减少460.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518816542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518816542?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:00","pubTimestamp":1741536051,"startTime":"0","endTime":"0","summary":"3月10日，Aquestive Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-44.14百万美元，同比减少460.86%；其中营业收入为57.56百万美元，同比增加13.80%，每股基本收益为-0.51美元。从资产负债表来看，Aquestive Therapeutics, Inc.总负债1.62亿美元，其中短期债务1.62百万美元，资产负债比为0.63，流动比率为4.68。机构评级：截至2025年3月10日，当前有9家机构对Aquestive Therapeutics, Inc.目标价做出预测，其中目标均价为9.86美元，其中最低目标价为4.75美元，最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000117abf1752c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000117abf1752c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","AQST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517465277","title":"Lake Street：维持Aquestive Therapeutics(AQST.US)评级，由买入调整至买入评级, 目标价由10.00美元调整至8.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517465277","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517465277?lang=zh_cn&edition=full","pubTime":"2025-03-08 05:23","pubTimestamp":1741382580,"startTime":"0","endTime":"0","summary":"Lake Street：维持Aquestive Therapeutics(AQST.US)评级，由买入调整至买入评级, 目标价由10.00美元调整至8.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08052348605264.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","AQST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517416555","title":"Aquestive Therapeutics, Inc.盘中异动 大幅下挫7.89%报2.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517416555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517416555?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:32","pubTimestamp":1741271551,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时32分，Aquestive Therapeutics, Inc.股票出现异动，股价大幅跳水7.89%。Aquestive Therapeutics, Inc.股票所在的制药行业中，整体跌幅为0.29%。其相关个股中，Scilex Holding Company C/Wts 10/11/2027 、博美集团、Scilex Holding Company涨幅较大，德纳维制药、Redhill Biopharma Ltd、苏轩堂较为活跃，换手率分别为6.71%、1.46%、1.04%，振幅较大的相关个股有大自然药业、Sunshine Biopharma Inc.、Aquestive Therapeutics, Inc.，振幅分别为6.41%、5.82%、5.02%。Aquestive Therapeutics, Inc.公司简介：Aquestive Therapeutics Inc 是一家专业制药公司，致力于开发和商业化差异化产品以满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223231a262900c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223231a262900c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AQST","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153579219","title":"Aquestive Therapeutics第四季度GAAP每股收益$(0.19)，逊于预期的$(0.14)，销售额$1187万低于预期的$1308万","url":"https://stock-news.laohu8.com/highlight/detail?id=1153579219","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153579219?lang=zh_cn&edition=full","pubTime":"2025-03-06 05:11","pubTimestamp":1741209082,"startTime":"0","endTime":"0","summary":"相比去年同期的每股亏损$，这是一个90％的下降。公司报告季度销售额为$1187万，低于分析师普遍预期的$1308万，差距为9.30％。这一数据相较去年同期的销售额$1321万下降了10.14%。以上内容来自Benzinga Earnings专栏，原文如下：Aquestive $Therapeutics$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 35.71 percent. This is a 90 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $11.87 million which missed the analyst consensus estimate of $13.08 million by 9.30 percent.  This is a 10.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AQST","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514016850","title":"Aquestive Therapeutics, Inc.盘中异动 早盘股价大跌5.05%报2.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514016850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514016850?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:36","pubTimestamp":1740497819,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时36分，Aquestive Therapeutics, Inc.股票出现异动，股价大幅跳水5.05%。Aquestive Therapeutics, Inc.股票所在的制药行业中，整体涨幅为1.75%。其相关个股中，Scilex Holding Company C/Wts 10/11/2027 、Cyclo Therapeutics Inc C/Wts 11/12/2025、Bausch Health Companies Inc.涨幅较大，Redhill Biopharma Ltd、Petros Pharmaceuticals, Inc.、苏轩堂较为活跃，换手率分别为162.26%、158.75%、66.24%，振幅较大的相关个股有Redhill Biopharma Ltd、Biofrontera Inc C/Wts 27/10/2026 、Sunshine Biopharma Inc C/Wts ，振幅分别为50.39%、43.55%、31.25%。Aquestive Therapeutics, Inc.公司简介：Aquestive Therapeutics Inc 是一家专业制药公司，致力于开发和商业化差异化产品以满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233700abdc8ece&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233700abdc8ece&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","AQST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512167467","title":"Aquestive Therapeutics, Inc.盘中异动 临近午盘快速下挫5.12%报3.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512167467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512167467?lang=zh_cn&edition=full","pubTime":"2025-02-19 00:43","pubTimestamp":1739897023,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日00时43分，Aquestive Therapeutics, Inc.股票出现异动，股价急速下挫5.12%。Aquestive Therapeutics, Inc.股票所在的制药行业中，整体涨幅为1.58%。其相关个股中，Painreform Ltd.、Flora Growth Corp.、Medicus Pharma Ltd.涨幅较大，Painreform Ltd.、Petros Pharmaceuticals, Inc.、大自然药业较为活跃，换手率分别为4706.40%、202.56%、10.49%，振幅较大的相关个股有Painreform Ltd.、Cyclo Therapeutics Inc C/Wts 11/12/2025、Sunshine Biopharma Inc C/Wts ，振幅分别为71.63%、35.46%、25.64%。Aquestive Therapeutics, Inc.公司简介：Aquestive Therapeutics Inc 是一家专业制药公司，致力于开发和商业化差异化产品以满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219004343abd3cb88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219004343abd3cb88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AQST","BK4007","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511883325","title":"Aquestive Therapeutics, Inc.盘中异动 快速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511883325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511883325?lang=zh_cn&edition=full","pubTime":"2025-02-13 01:08","pubTimestamp":1739380088,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日01时08分，Aquestive Therapeutics, Inc.股票出现异动，股价快速拉升5.05%。Aquestive Therapeutics, Inc.股票所在的制药行业中，整体涨幅为0.52%。其相关个股中，吉利德科学、Shuttle Pharmaceuticals Holdings, Inc.、Aquestive Therapeutics, Inc.涨幅较大，大自然药业、Inmed Pharmaceuticals Inc.、Quantum Biopharma Ltd.较为活跃，换手率分别为22.91%、20.12%、15.31%，振幅较大的相关个股有Biofrontera Inc C/Wts 27/10/2026 、Sunshine Biopharma Inc C/Wts 、Cyclo Therapeutics, Inc.，振幅分别为57.35%、28.47%、11.39%。Aquestive Therapeutics, Inc.公司简介：Aquestive Therapeutics Inc 是一家专业制药公司，致力于开发和商业化差异化产品以满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213010808a24375e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213010808a24375e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","AQST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509496914","title":"Aquestive Therapeutics, Inc.盘中异动 快速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509496914","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509496914?lang=zh_cn&edition=full","pubTime":"2025-02-05 04:07","pubTimestamp":1738699634,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日04时07分，Aquestive Therapeutics, Inc.股票出现异动，股价快速上涨5.02%。截至发稿，该股报3.04美元/股，成交量65.4547万股，换手率0.72%，振幅4.65%。Aquestive Therapeutics, Inc.股票所在的制药行业中，整体涨幅为0.93%。Aquestive Therapeutics, Inc.公司简介：Aquestive Therapeutics Inc 是一家专业制药公司，致力于开发和商业化差异化产品以满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205040714abc2654f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205040714abc2654f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AQST","BK4139","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507233545","title":"Aquestive Therapeutics, Inc.盘中异动 临近午盘大幅上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507233545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507233545?lang=zh_cn&edition=full","pubTime":"2025-01-29 01:00","pubTimestamp":1738083622,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日01时00分，Aquestive Therapeutics, Inc.股票出现波动，股价大幅上涨5.02%。Aquestive Therapeutics, Inc.股票所在的制药行业中，整体跌幅为0.27%。其相关个股中，Cbdmd, Inc.、Painreform Ltd.、Mira Pharmaceuticals, Inc.涨幅较大，Cbdmd, Inc.、Painreform Ltd.、Inmed Pharmaceuticals Inc.较为活跃，换手率分别为230.95%、21.08%、5.66%，振幅较大的相关个股有Cbdmd, Inc.、Painreform Ltd.、Durect Corporation，振幅分别为48.61%、13.35%、12.94%。Aquestive Therapeutics, Inc.公司简介：Aquestive Therapeutics Inc 是一家专业制药公司，致力于开发和商业化差异化产品以满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129010023abbb83f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129010023abbb83f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AQST","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503762324","title":"Aquestive Therapeutics, Inc.盘中异动 早盘股价大涨5.08%报3.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503762324","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503762324?lang=zh_cn&edition=full","pubTime":"2025-01-15 23:24","pubTimestamp":1736954646,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日23时24分，Aquestive Therapeutics, Inc.股票出现异动，股价快速拉升5.08%。Aquestive Therapeutics, Inc.股票所在的制药行业中，整体涨幅为0.48%。其相关个股中，Inmed Pharmaceuticals Inc.、Therapeuticsmd, Inc.、Organogenesis Holdings Inc.涨幅较大，大自然药业、Cbdmd, Inc.、Akanda Corp.较为活跃，换手率分别为17.88%、6.70%、4.70%，振幅较大的相关个股有Talphera, Inc.、Petros Pharmaceuticals, Inc.、坎伯兰药业，振幅分别为11.86%、10.50%、10.49%。Aquestive Therapeutics, Inc.公司简介：Aquestive Therapeutics Inc 是一家专业制药公司，致力于开发和商业化差异化产品以满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115232406a2230bd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115232406a2230bd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","AQST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://aquestive.com","stockEarnings":[{"period":"1week","weight":-0.0347},{"period":"1month","weight":-0.0165},{"period":"3month","weight":0.1425},{"period":"6month","weight":-0.2263},{"period":"1year","weight":0.7521},{"period":"ytd","weight":-0.3545}],"compareEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":0.056},{"period":"3month","weight":0.0842},{"period":"6month","weight":0.1001},{"period":"1year","weight":0.2519},{"period":"ytd","weight":0.084}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aquestive Therapeutics, Inc.于2004年1月在特拉华州成立。该公司是一家通过创新递送技术推进药物的制药企业，专注于开发侵入性标准疗法的替代方案。它开发包括用于过敏性休克的肾上腺素前药在内的专有候选药物，并拥有由其工厂生产的授权商业化产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.125,"avgChangeRate":-0.146046},{"month":2,"riseRate":0.5,"avgChangeRate":0.102948},{"month":3,"riseRate":0.625,"avgChangeRate":0.025902},{"month":4,"riseRate":0.375,"avgChangeRate":0.009276},{"month":5,"riseRate":0.375,"avgChangeRate":-0.009055},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.04583},{"month":7,"riseRate":0.714286,"avgChangeRate":0.137421},{"month":8,"riseRate":0.75,"avgChangeRate":0.235449},{"month":9,"riseRate":0.25,"avgChangeRate":-0.03707},{"month":10,"riseRate":0.625,"avgChangeRate":0.042452},{"month":11,"riseRate":0.625,"avgChangeRate":0.192185},{"month":12,"riseRate":0.125,"avgChangeRate":-0.186183}],"exchange":"NASDAQ","name":"Aquestive Therapeutics Inc.","nameEN":"Aquestive Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aquestive Therapeutics Inc.(AQST)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aquestive Therapeutics Inc.(AQST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aquestive Therapeutics Inc.,AQST,Aquestive Therapeutics Inc.股票,Aquestive Therapeutics Inc.股票老虎,Aquestive Therapeutics Inc.股票老虎国际,Aquestive Therapeutics Inc.行情,Aquestive Therapeutics Inc.股票行情,Aquestive Therapeutics Inc.股价,Aquestive Therapeutics Inc.股市,Aquestive Therapeutics Inc.股票价格,Aquestive Therapeutics Inc.股票交易,Aquestive Therapeutics Inc.股票购买,Aquestive Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aquestive Therapeutics Inc.(AQST)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aquestive Therapeutics Inc.(AQST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}